Join us at Curecast
On November 6, Katie Couric, leading experts, and advocates will share how Project Cure CRC is transforming research and advancing care.




Your doctor will test your blood for CEA levels after you are diagnosed with colorectal cancer, during treatment, and during follow-up visits.

Knowing the details of tumor biomarkers can help you and your doctor make decisions about personalized treatment with therapies tailored specifically to the characteristics of your tumor.

While CEA biomarker testing is commonly performed during colorectal cancer diagnosis, treatment, and follow-up care, it has limitations because the test can sometimes result in false positives or negatives.
If a CEA level is low, it does not always mean that the cancer has not come back.
If a CEA level is high, it does not always mean that the cancer has come back. It may take additional testing to confirm the results of your CEA testing.

When Kate Shin’s mother faced rectal cancer, clinical trials gave them precious time together. Now, Kate shares her story to encourage access to screening and innovative care, including clinical trials.

The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.

After a stage IV colorectal cancer diagnosis, Heather’s biomarker test revealed a critical mutation — opening the door to clinical trials and new hope.